| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | immunoglobulin receptor binding | 3.45e-06 | 21 | 101 | 4 | GO:0034987 | |
| GeneOntologyMolecularFunction | Fc-gamma receptor I complex binding | 4.33e-06 | 7 | 101 | 3 | GO:0034988 | |
| GeneOntologyMolecularFunction | benzodiazepine receptor activity | 2.01e-05 | 11 | 101 | 3 | GO:0008503 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 2.25e-05 | 33 | 101 | 4 | GO:0033764 | |
| GeneOntologyMolecularFunction | cholesterol dehydrogenase activity | 2.53e-05 | 2 | 101 | 2 | GO:0102294 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 4.16e-05 | 125 | 101 | 6 | GO:0015108 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity | 4.43e-05 | 39 | 101 | 4 | GO:0016229 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 4.55e-05 | 127 | 101 | 6 | GO:0016616 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 7.23e-05 | 138 | 101 | 6 | GO:0016614 | |
| GeneOntologyMolecularFunction | chloride channel activity | 7.54e-05 | 86 | 101 | 5 | GO:0005254 | |
| GeneOntologyMolecularFunction | L-isoleucine transmembrane transporter activity | 7.57e-05 | 3 | 101 | 2 | GO:0015188 | |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 9.70e-05 | 18 | 101 | 3 | GO:0022851 | |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 1.15e-04 | 19 | 101 | 3 | GO:0004890 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 1.19e-04 | 151 | 101 | 6 | GO:0008509 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 1.77e-04 | 103 | 101 | 5 | GO:0005253 | |
| GeneOntologyMolecularFunction | GABA receptor activity | 1.80e-04 | 22 | 101 | 3 | GO:0016917 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 2.34e-04 | 171 | 101 | 6 | GO:0015103 | |
| GeneOntologyMolecularFunction | transporter activity | SLC43A2 ATP7B PKD1L1 SPNS3 ATP10A SLC2A2 CLDN2 SLC6A11 CLCN5 SLC44A5 SURF1 SLC6A20 SLC26A11 KCNT1 GABRA3 GABRA4 GABRA6 | 2.41e-04 | 1289 | 101 | 17 | GO:0005215 |
| GeneOntologyMolecularFunction | alpha-1,4-glucosidase activity | 2.51e-04 | 5 | 101 | 2 | GO:0004558 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC43A2 ATP7B PKD1L1 SPNS3 SLC2A2 CLDN2 SLC6A11 CLCN5 SLC44A5 SURF1 SLC6A20 SLC26A11 KCNT1 GABRA3 GABRA4 GABRA6 | 2.75e-04 | 1180 | 101 | 16 | GO:0022857 |
| GeneOntologyMolecularFunction | 3-beta-hydroxy-delta5-steroid dehydrogenase (NAD+) activity | 3.75e-04 | 6 | 101 | 2 | GO:0003854 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 4.62e-04 | 30 | 101 | 3 | GO:0018455 | |
| GeneOntologyMolecularFunction | steroid delta-isomerase activity | 5.23e-04 | 7 | 101 | 2 | GO:0004769 | |
| GeneOntologyMolecularFunction | alpha-glucosidase activity | 5.23e-04 | 7 | 101 | 2 | GO:0090599 | |
| GeneOntologyMolecularFunction | 5alpha-androstane-3beta,17beta-diol dehydrogenase activity | 6.95e-04 | 8 | 101 | 2 | GO:0047024 | |
| GeneOntologyMolecularFunction | 3-keto sterol reductase activity | 6.95e-04 | 8 | 101 | 2 | GO:0000253 | |
| GeneOntologyMolecularFunction | branched-chain amino acid transmembrane transporter activity | 1.11e-03 | 10 | 101 | 2 | GO:0015658 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ATP7B PKD1L1 SLC6A11 CLCN5 SURF1 SLC6A20 SLC26A11 KCNT1 GABRA3 GABRA4 GABRA6 | 1.56e-03 | 758 | 101 | 11 | GO:0015318 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 2.07e-03 | 50 | 101 | 3 | GO:0099095 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | ATP7B PKD1L1 SLC6A11 CLCN5 SURF1 SLC6A20 SLC26A11 KCNT1 GABRA3 GABRA4 GABRA6 | 2.23e-03 | 793 | 101 | 11 | GO:0015075 |
| GeneOntologyMolecularFunction | glucosidase activity | 2.55e-03 | 15 | 101 | 2 | GO:0015926 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 3.01e-03 | 57 | 101 | 3 | GO:1904315 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 3.49e-03 | 60 | 101 | 3 | GO:0099529 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 3.65e-03 | 61 | 101 | 3 | GO:1901682 | |
| GeneOntologyMolecularFunction | intramolecular oxidoreductase activity, transposing C=C bonds | 4.10e-03 | 19 | 101 | 2 | GO:0016863 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 4.37e-03 | 65 | 101 | 3 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 4.37e-03 | 65 | 101 | 3 | GO:0022824 | |
| GeneOntologyMolecularFunction | estradiol 17-beta-dehydrogenase [NAD(P)+] activity | 4.54e-03 | 20 | 101 | 2 | GO:0004303 | |
| GeneOntologyMolecularFunction | channel activity | 5.17e-03 | 525 | 101 | 8 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 5.23e-03 | 526 | 101 | 8 | GO:0022803 | |
| GeneOntologyMolecularFunction | amino acid:sodium symporter activity | 5.98e-03 | 23 | 101 | 2 | GO:0005283 | |
| GeneOntologyMolecularFunction | NAD binding | 6.05e-03 | 73 | 101 | 3 | GO:0051287 | |
| GeneOntologyMolecularFunction | GTP-dependent protein binding | 6.50e-03 | 24 | 101 | 2 | GO:0030742 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 6.50e-03 | 24 | 101 | 2 | GO:0004745 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 6.52e-03 | 75 | 101 | 3 | GO:0098960 | |
| GeneOntologyBiologicalProcess | positive regulation of type IIa hypersensitivity | 5.69e-10 | 10 | 99 | 5 | GO:0001798 | |
| GeneOntologyBiologicalProcess | positive regulation of type II hypersensitivity | 5.69e-10 | 10 | 99 | 5 | GO:0002894 | |
| GeneOntologyBiologicalProcess | regulation of type IIa hypersensitivity | 1.04e-09 | 11 | 99 | 5 | GO:0001796 | |
| GeneOntologyBiologicalProcess | regulation of type II hypersensitivity | 1.04e-09 | 11 | 99 | 5 | GO:0002892 | |
| GeneOntologyBiologicalProcess | type IIa hypersensitivity | 6.65e-09 | 15 | 99 | 5 | GO:0001794 | |
| GeneOntologyBiologicalProcess | positive regulation of hypersensitivity | 6.65e-09 | 15 | 99 | 5 | GO:0002885 | |
| GeneOntologyBiologicalProcess | type II hypersensitivity | 6.65e-09 | 15 | 99 | 5 | GO:0002445 | |
| GeneOntologyBiologicalProcess | positive regulation of acute inflammatory response to antigenic stimulus | 1.36e-08 | 17 | 99 | 5 | GO:0002866 | |
| GeneOntologyBiologicalProcess | regulation of hypersensitivity | 2.54e-08 | 19 | 99 | 5 | GO:0002883 | |
| GeneOntologyBiologicalProcess | positive regulation of inflammatory response to antigenic stimulus | 7.23e-08 | 23 | 99 | 5 | GO:0002863 | |
| GeneOntologyBiologicalProcess | hypersensitivity | 1.13e-07 | 25 | 99 | 5 | GO:0002524 | |
| GeneOntologyBiologicalProcess | regulation of acute inflammatory response to antigenic stimulus | 1.71e-07 | 27 | 99 | 5 | GO:0002864 | |
| GeneOntologyBiologicalProcess | positive regulation of myeloid leukocyte mediated immunity | 2.98e-07 | 30 | 99 | 5 | GO:0002888 | |
| GeneOntologyBiologicalProcess | antibody-dependent cellular cytotoxicity | 3.45e-07 | 13 | 99 | 4 | GO:0001788 | |
| GeneOntologyBiologicalProcess | positive regulation of phagocytosis | 4.91e-07 | 99 | 99 | 7 | GO:0050766 | |
| GeneOntologyBiologicalProcess | positive regulation of endocytosis | 8.74e-07 | 213 | 99 | 9 | GO:0045807 | |
| GeneOntologyBiologicalProcess | positive regulation of acute inflammatory response | 1.70e-06 | 42 | 99 | 5 | GO:0002675 | |
| GeneOntologyBiologicalProcess | acute inflammatory response to antigenic stimulus | 1.70e-06 | 42 | 99 | 5 | GO:0002438 | |
| GeneOntologyBiologicalProcess | complement activation, classical pathway | 2.15e-06 | 44 | 99 | 5 | GO:0006958 | |
| GeneOntologyBiologicalProcess | regulation of myeloid leukocyte mediated immunity | 2.55e-06 | 81 | 99 | 6 | GO:0002886 | |
| GeneOntologyBiologicalProcess | regulation of phagocytosis | 4.17e-06 | 136 | 99 | 7 | GO:0050764 | |
| GeneOntologyBiologicalProcess | positive regulation of type I hypersensitivity | 5.90e-06 | 8 | 99 | 3 | GO:0001812 | |
| GeneOntologyBiologicalProcess | positive regulation of B cell mediated immunity | 7.24e-06 | 56 | 99 | 5 | GO:0002714 | |
| GeneOntologyBiologicalProcess | positive regulation of immunoglobulin mediated immune response | 7.24e-06 | 56 | 99 | 5 | GO:0002891 | |
| GeneOntologyBiologicalProcess | regulation of type I hypersensitivity | 8.82e-06 | 9 | 99 | 3 | GO:0001810 | |
| GeneOntologyBiologicalProcess | regulation of inflammatory response to antigenic stimulus | 1.11e-05 | 61 | 99 | 5 | GO:0002861 | |
| GeneOntologyBiologicalProcess | humoral immune response mediated by circulating immunoglobulin | 1.20e-05 | 62 | 99 | 5 | GO:0002455 | |
| GeneOntologyBiologicalProcess | type I hypersensitivity | 1.26e-05 | 10 | 99 | 3 | GO:0016068 | |
| GeneOntologyBiologicalProcess | import into cell | SLC43A2 SYNE1 HEATR5A WNK1 AP3M1 TBC1D24 SLC6A11 CLCN5 FCGR1A IGHG1 IGHG3 IGHG4 IGHM SLC6A20 LRP1 C3 HSPA8 | 1.30e-05 | 1074 | 99 | 17 | GO:0098657 |
| GeneOntologyBiologicalProcess | regulation of acute inflammatory response | 1.76e-05 | 67 | 99 | 5 | GO:0002673 | |
| GeneOntologyBiologicalProcess | phagocytosis, engulfment | 2.03e-05 | 69 | 99 | 5 | GO:0006911 | |
| GeneOntologyBiologicalProcess | complement activation | 2.17e-05 | 70 | 99 | 5 | GO:0006956 | |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion mediated by integrin | 2.29e-05 | 12 | 99 | 3 | GO:0033632 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 2.60e-05 | 180 | 99 | 7 | GO:0060078 | |
| GeneOntologyBiologicalProcess | regulation of immune effector process | 2.66e-05 | 497 | 99 | 11 | GO:0002697 | |
| GeneOntologyBiologicalProcess | plasma membrane invagination | 3.68e-05 | 78 | 99 | 5 | GO:0099024 | |
| GeneOntologyBiologicalProcess | regulation of B cell mediated immunity | 3.91e-05 | 79 | 99 | 5 | GO:0002712 | |
| GeneOntologyBiologicalProcess | regulation of immunoglobulin mediated immune response | 3.91e-05 | 79 | 99 | 5 | GO:0002889 | |
| GeneOntologyBiologicalProcess | cell recognition | 4.77e-05 | 198 | 99 | 7 | GO:0008037 | |
| GeneOntologyBiologicalProcess | phagocytosis, recognition | 4.86e-05 | 42 | 99 | 4 | GO:0006910 | |
| GeneOntologyBiologicalProcess | membrane invagination | 6.23e-05 | 87 | 99 | 5 | GO:0010324 | |
| GeneOntologyBiologicalProcess | myeloid leukocyte mediated immunity | 7.98e-05 | 148 | 99 | 6 | GO:0002444 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte mediated immunity | 8.60e-05 | 150 | 99 | 6 | GO:0002708 | |
| GeneOntologyBiologicalProcess | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 8.60e-05 | 150 | 99 | 6 | GO:0002824 | |
| GeneOntologyBiologicalProcess | lysosomal transport | 8.92e-05 | 151 | 99 | 6 | GO:0007041 | |
| GeneOntologyBiologicalProcess | early endosome to late endosome transport | 9.71e-05 | 50 | 99 | 4 | GO:0045022 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion mediated by integrin | 9.83e-05 | 19 | 99 | 3 | GO:0033631 | |
| GeneOntologyBiologicalProcess | regulation of endocytosis | 1.07e-04 | 389 | 99 | 9 | GO:0030100 | |
| GeneOntologyBiologicalProcess | positive regulation of adaptive immune response | 1.18e-04 | 159 | 99 | 6 | GO:0002821 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated immunity | 1.22e-04 | 309 | 99 | 8 | GO:0002703 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte mediated immunity | 1.29e-04 | 232 | 99 | 7 | GO:0002706 | |
| GeneOntologyBiologicalProcess | inflammatory response to antigenic stimulus | 1.39e-04 | 103 | 99 | 5 | GO:0002437 | |
| GeneOntologyBiologicalProcess | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.39e-04 | 235 | 99 | 7 | GO:0002822 | |
| GeneOntologyBiologicalProcess | vesicle-mediated transport between endosomal compartments | 1.51e-04 | 56 | 99 | 4 | GO:0098927 | |
| GeneOntologyBiologicalProcess | endocytosis | SYNE1 HEATR5A AP3M1 TBC1D24 CLCN5 FCGR1A IGHG1 IGHG3 IGHG4 IGHM LRP1 C3 HSPA8 | 1.61e-04 | 827 | 99 | 13 | GO:0006897 |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte mediated immunity | 2.00e-04 | 175 | 99 | 6 | GO:0002705 | |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 2.06e-04 | 112 | 99 | 5 | GO:1902476 | |
| GeneOntologyBiologicalProcess | regulation of adaptive immune response | 2.14e-04 | 252 | 99 | 7 | GO:0002819 | |
| GeneOntologyBiologicalProcess | isoleucine transport | 2.26e-04 | 5 | 99 | 2 | GO:0015818 | |
| GeneOntologyBiologicalProcess | immune effector process | DDX60 MUC19 CD84 CLC FCGR1A IGHG1 IGHG3 IGHG4 IGHM LRP1 C3 ZPBP2 HSPA8 | 2.34e-04 | 859 | 99 | 13 | GO:0002252 |
| GeneOntologyBiologicalProcess | vacuolar transport | 2.86e-04 | 187 | 99 | 6 | GO:0007034 | |
| GeneOntologyBiologicalProcess | negative regulation of iron ion transport | 3.38e-04 | 6 | 99 | 2 | GO:0034757 | |
| GeneOntologyBiologicalProcess | regulation of vesicle-mediated transport | UNC13B SYNE1 CD84 FCGR1A IGHG1 IGHG3 IGHG4 IGHM LRP1 C3 HSPA8 | 3.55e-04 | 667 | 99 | 11 | GO:0060627 |
| GeneOntologyBiologicalProcess | phagocytosis | 3.56e-04 | 274 | 99 | 7 | GO:0006909 | |
| GeneOntologyBiologicalProcess | chloride transport | 3.82e-04 | 128 | 99 | 5 | GO:0006821 | |
| GeneOntologyBiologicalProcess | inhibitory synapse assembly | 3.96e-04 | 30 | 99 | 3 | GO:1904862 | |
| GeneOntologyBiologicalProcess | synapse organization | UNC13B NRCAM PODXL RYK C1QL1 C3 ADGRL2 HSPA8 GABRA3 GABRA4 GABRA6 | 4.45e-04 | 685 | 99 | 11 | GO:0050808 |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 4.71e-04 | 134 | 99 | 5 | GO:0098661 | |
| GeneOntologyBiologicalProcess | positive regulation of cell-cell adhesion mediated by integrin | 4.71e-04 | 7 | 99 | 2 | GO:0033634 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation | 5.57e-04 | 139 | 99 | 5 | GO:0019882 | |
| GeneOntologyBiologicalProcess | B cell receptor signaling pathway | 5.69e-04 | 79 | 99 | 4 | GO:0050853 | |
| GeneOntologyBiologicalProcess | immune response-regulating cell surface receptor signaling pathway | 6.12e-04 | 393 | 99 | 8 | GO:0002768 | |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid signaling pathway | 6.28e-04 | 35 | 99 | 3 | GO:0007214 | |
| GeneOntologyBiologicalProcess | acute inflammatory response | 6.33e-04 | 143 | 99 | 5 | GO:0002526 | |
| GeneOntologyBiologicalProcess | positive regulation of transport | UNC13B SYNE1 WNK1 SLC2A2 FCGR1A IGHG1 IGHG3 IGHG4 IGHM LRP1 NADK C3 HSPA8 HCLS1 | 6.40e-04 | 1081 | 99 | 14 | GO:0051050 |
| GeneOntologyBiologicalProcess | cell killing | 6.99e-04 | 307 | 99 | 7 | GO:0001906 | |
| GeneOntologyBiologicalProcess | synapse assembly | 7.13e-04 | 308 | 99 | 7 | GO:0007416 | |
| GeneOntologyBiologicalProcess | antigen receptor-mediated signaling pathway | 7.25e-04 | 223 | 99 | 6 | GO:0050851 | |
| GeneOntologyBiologicalProcess | immune response-regulating signaling pathway | 7.43e-04 | 615 | 99 | 10 | GO:0002764 | |
| GeneOntologyBiologicalProcess | antibacterial humoral response | 7.51e-04 | 85 | 99 | 4 | GO:0019731 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | UNC13B PCSK5 SYNE1 FYCO1 WNK1 ATP10A TBC1D24 FCGR1A IGHG1 IGHG3 IGHG4 IGHM LRP1 C3 ADGRL2 HSPA8 | 7.64e-04 | 1366 | 99 | 16 | GO:0051130 |
| GeneOntologyBiologicalProcess | cell junction organization | UNC13B NRCAM PODXL CLDN2 RYK C1QL1 LRP1 C3 ADGRL2 HSPA8 GABRA3 GABRA4 GABRA6 | 7.68e-04 | 974 | 99 | 13 | GO:0034330 |
| GeneOntologyBiologicalProcess | androgen metabolic process | 8.01e-04 | 38 | 99 | 3 | GO:0008209 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | ATP7B PKD1L1 WNK1 ATP10A CD84 SLC6A11 CLCN5 SURF1 SLC6A20 HSD3B1 HSD3B2 SLC26A11 KCNT1 GABRA3 GABRA4 GABRA6 | 8.13e-04 | 1374 | 99 | 16 | GO:0006811 |
| GeneOntologyBiologicalProcess | positive regulation of immune effector process | 8.44e-04 | 317 | 99 | 7 | GO:0002699 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 8.59e-04 | 153 | 99 | 5 | GO:0098656 | |
| GeneOntologyBiologicalProcess | immunoglobulin mediated immune response | 9.52e-04 | 235 | 99 | 6 | GO:0016064 | |
| GeneOntologyBiologicalProcess | lymphocyte anergy | 1.00e-03 | 10 | 99 | 2 | GO:0002249 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity | 1.00e-03 | 10 | 99 | 2 | GO:1990264 | |
| GeneOntologyBiologicalProcess | regulation of T cell anergy | 1.00e-03 | 10 | 99 | 2 | GO:0002667 | |
| GeneOntologyBiologicalProcess | T cell anergy | 1.00e-03 | 10 | 99 | 2 | GO:0002870 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte anergy | 1.00e-03 | 10 | 99 | 2 | GO:0002911 | |
| GeneOntologyBiologicalProcess | immunoglobulin production | 1.08e-03 | 241 | 99 | 6 | GO:0002377 | |
| GeneOntologyBiologicalProcess | B cell mediated immunity | 1.15e-03 | 244 | 99 | 6 | GO:0019724 | |
| GeneOntologyBiologicalProcess | immune response-activating signaling pathway | 1.37e-03 | 553 | 99 | 9 | GO:0002757 | |
| GeneOntologyBiologicalProcess | positive regulation of B cell activation | 1.38e-03 | 100 | 99 | 4 | GO:0050871 | |
| GeneOntologyBiologicalProcess | lymphocyte mediated immunity | 1.44e-03 | 449 | 99 | 8 | GO:0002449 | |
| GeneOntologyBiologicalProcess | androgen biosynthetic process | 1.46e-03 | 12 | 99 | 2 | GO:0006702 | |
| GeneOntologyBiologicalProcess | regulation of iron ion transport | 1.46e-03 | 12 | 99 | 2 | GO:0034756 | |
| GeneOntologyBiologicalProcess | regulation of response to external stimulus | UNC13B DDX60 CD109 MUC19 MUC16 WNK1 RYK CD84 FCGR1A IGHG1 IGHG3 IGHG4 LRP1 C3 HSPA8 | 1.49e-03 | 1316 | 99 | 15 | GO:0032101 |
| GeneOntologyCellularComponent | immunoglobulin complex, circulating | 1.16e-06 | 17 | 101 | 4 | GO:0042571 | |
| GeneOntologyCellularComponent | postsynaptic membrane | NRCAM SYNE1 RYK SLC6A11 LRP1 ADGRL2 KCNT1 HSPA8 GABRA3 GABRA4 GABRA6 | 4.20e-06 | 405 | 101 | 11 | GO:0045211 |
| GeneOntologyCellularComponent | synaptic membrane | UNC13B NRCAM PODXL SYNE1 RYK SLC6A11 LRP1 ADGRL2 KCNT1 HSPA8 GABRA3 GABRA4 GABRA6 | 4.67e-06 | 583 | 101 | 13 | GO:0097060 |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 5.98e-06 | 201 | 101 | 8 | GO:0099634 | |
| GeneOntologyCellularComponent | blood microparticle | 6.37e-06 | 144 | 101 | 7 | GO:0072562 | |
| GeneOntologyCellularComponent | IgG immunoglobulin complex | 3.83e-05 | 14 | 101 | 3 | GO:0071735 | |
| GeneOntologyCellularComponent | GABA-A receptor complex | 1.00e-04 | 19 | 101 | 3 | GO:1902711 | |
| GeneOntologyCellularComponent | apical part of cell | RAPGEF6 ATP7B PODXL SI SLC2A2 CLCN5 PTPRQ SLC6A20 LRP1 SLC26A11 MUC20 | 1.36e-04 | 592 | 101 | 11 | GO:0045177 |
| GeneOntologyCellularComponent | GABA receptor complex | 1.37e-04 | 21 | 101 | 3 | GO:1902710 | |
| GeneOntologyCellularComponent | Golgi lumen | 1.87e-04 | 109 | 101 | 5 | GO:0005796 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 2.08e-04 | 519 | 101 | 10 | GO:0009897 | |
| GeneOntologyCellularComponent | side of membrane | NRCAM CD109 MUC16 CD84 CD3E FCGR1A IGHG1 IGHG3 IGHG4 IGHM LRP1 HSPA8 | 1.04e-03 | 875 | 101 | 12 | GO:0098552 |
| GeneOntologyCellularComponent | cell projection membrane | 1.16e-03 | 431 | 101 | 8 | GO:0031253 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 1.21e-03 | 164 | 101 | 5 | GO:0098982 | |
| GeneOntologyCellularComponent | postsynapse | NRCAM SYNE1 AP3M1 RYK SLC6A11 CD3E LRP1 ADGRL2 KCNT1 HSPA8 GABRA3 GABRA4 GABRA6 | 1.23e-03 | 1018 | 101 | 13 | GO:0098794 |
| GeneOntologyCellularComponent | smooth endoplasmic reticulum membrane | 1.48e-03 | 12 | 101 | 2 | GO:0030868 | |
| GeneOntologyCellularComponent | basal plasma membrane | 1.66e-03 | 354 | 101 | 7 | GO:0009925 | |
| GeneOntologyCellularComponent | receptor complex | 2.01e-03 | 581 | 101 | 9 | GO:0043235 | |
| GeneOntologyCellularComponent | presynaptic membrane | 2.27e-03 | 277 | 101 | 6 | GO:0042734 | |
| GeneOntologyCellularComponent | basal part of cell | 2.40e-03 | 378 | 101 | 7 | GO:0045178 | |
| GeneOntologyCellularComponent | apical plasma membrane | 2.50e-03 | 487 | 101 | 8 | GO:0016324 | |
| GeneOntologyCellularComponent | dendrite membrane | 2.52e-03 | 56 | 101 | 3 | GO:0032590 | |
| GeneOntologyCellularComponent | chloride channel complex | 2.65e-03 | 57 | 101 | 3 | GO:0034707 | |
| GeneOntologyCellularComponent | cell surface | NRCAM CD109 MUC16 CD84 CD3E FCGR1A IGHG1 IGHG3 IGHG4 IGHM LRP1 C3 HSPA8 | 2.66e-03 | 1111 | 101 | 13 | GO:0009986 |
| GeneOntologyCellularComponent | mitochondrial crista | 3.00e-03 | 17 | 101 | 2 | GO:0030061 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 3.04e-03 | 503 | 101 | 8 | GO:0099572 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 3.85e-03 | 523 | 101 | 8 | GO:0098984 | |
| MousePheno | absent memory B cells | 9.27e-07 | 4 | 87 | 3 | MP:0008094 | |
| MousePheno | abnormal plasma cell differentiation | 1.81e-06 | 15 | 87 | 4 | MP:0008099 | |
| MousePheno | decreased memory B cell number | 1.90e-05 | 9 | 87 | 3 | MP:0008729 | |
| MousePheno | decreased IgG2c level | 3.71e-05 | 11 | 87 | 3 | MP:0008897 | |
| MousePheno | abnormal memory B cell number | 3.71e-05 | 11 | 87 | 3 | MP:0008093 | |
| MousePheno | abnormal memory B cell morphology | 8.07e-05 | 14 | 87 | 3 | MP:0002440 | |
| MousePheno | abnormal plasma cell morphology | 1.02e-04 | 75 | 87 | 5 | MP:0002439 | |
| MousePheno | increased plasma cell number | 1.08e-04 | 40 | 87 | 4 | MP:0008097 | |
| MousePheno | increased tear production | 1.14e-04 | 3 | 87 | 2 | MP:0020219 | |
| MousePheno | abnormal class switch recombination | 1.47e-04 | 81 | 87 | 5 | MP:0004816 | |
| MousePheno | enhanced humoral immune response | 1.49e-04 | 17 | 87 | 3 | MP:0020155 | |
| MousePheno | abnormal IgG2c level | 2.86e-04 | 21 | 87 | 3 | MP:0020178 | |
| MousePheno | abnormal germinal center B cell number | 3.75e-04 | 55 | 87 | 4 | MP:0013680 | |
| MousePheno | abnormal germinal center B cell morphology | 3.75e-04 | 55 | 87 | 4 | MP:0008176 | |
| MousePheno | decreased susceptibility to autoimmune hemolytic anemia | 3.78e-04 | 5 | 87 | 2 | MP:0004828 | |
| Domain | GABAAa_rcpt | 2.86e-06 | 6 | 99 | 3 | IPR001390 | |
| Domain | Ig/MHC_CS | 1.39e-05 | 58 | 99 | 5 | IPR003006 | |
| Domain | IG_MHC | 1.64e-05 | 60 | 99 | 5 | PS00290 | |
| Domain | - | 3.25e-05 | 169 | 99 | 7 | 3.40.50.720 | |
| Domain | NAD(P)-bd_dom | 3.77e-05 | 173 | 99 | 7 | IPR016040 | |
| Domain | Gal_mutarotase_N | 1.66e-04 | 4 | 99 | 2 | IPR031727 | |
| Domain | NtCtMGAM_N | 1.66e-04 | 4 | 99 | 2 | PF16863 | |
| Domain | C1-set | 1.92e-04 | 54 | 99 | 4 | PF07654 | |
| Domain | IGc1 | 2.21e-04 | 56 | 99 | 4 | SM00407 | |
| Domain | GABAA/Glycine_rcpt | 2.37e-04 | 23 | 99 | 3 | IPR006028 | |
| Domain | Ig_C1-set | 2.53e-04 | 58 | 99 | 4 | IPR003597 | |
| Domain | Glyco_hydro_31_AS | 4.11e-04 | 6 | 99 | 2 | IPR030458 | |
| Domain | 3Beta_HSD | 4.11e-04 | 6 | 99 | 2 | PF01073 | |
| Domain | 3Beta_OHSteriod_DH/Estase | 4.11e-04 | 6 | 99 | 2 | IPR002225 | |
| Domain | Glyco_hydro_31 | 5.74e-04 | 7 | 99 | 2 | IPR000322 | |
| Domain | PKD | 5.74e-04 | 7 | 99 | 2 | PF00801 | |
| Domain | Glyco_hydro_31 | 5.74e-04 | 7 | 99 | 2 | PF01055 | |
| Domain | GLYCOSYL_HYDROL_F31_1 | 5.74e-04 | 7 | 99 | 2 | PS00129 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 7.63e-04 | 8 | 99 | 2 | IPR019565 | |
| Domain | Thiol-ester_cl | 7.63e-04 | 8 | 99 | 2 | PF10569 | |
| Domain | Trefoil | 7.63e-04 | 8 | 99 | 2 | PF00088 | |
| Domain | MacrogloblnA2_CS | 7.63e-04 | 8 | 99 | 2 | IPR019742 | |
| Domain | A2M_N_2 | 7.63e-04 | 8 | 99 | 2 | SM01359 | |
| Domain | - | 7.63e-04 | 8 | 99 | 2 | 2.60.40.690 | |
| Domain | A2M_recep | 7.63e-04 | 8 | 99 | 2 | SM01361 | |
| Domain | A2M | 7.63e-04 | 8 | 99 | 2 | SM01360 | |
| Domain | Sc_DH/Rdtase_CS | 8.36e-04 | 35 | 99 | 3 | IPR020904 | |
| Domain | GPS | 9.08e-04 | 36 | 99 | 3 | PS50221 | |
| Domain | P_TREFOIL_2 | 9.77e-04 | 9 | 99 | 2 | PS51448 | |
| Domain | PKD/Chitinase_dom | 9.77e-04 | 9 | 99 | 2 | IPR022409 | |
| Domain | PKD | 9.77e-04 | 9 | 99 | 2 | SM00089 | |
| Domain | PD | 9.77e-04 | 9 | 99 | 2 | SM00018 | |
| Domain | GPS | 9.85e-04 | 37 | 99 | 3 | IPR000203 | |
| Domain | A2M | 1.22e-03 | 10 | 99 | 2 | PF00207 | |
| Domain | A2M_N_2 | 1.22e-03 | 10 | 99 | 2 | IPR011625 | |
| Domain | A2M_comp | 1.22e-03 | 10 | 99 | 2 | IPR011626 | |
| Domain | A2M_recep | 1.22e-03 | 10 | 99 | 2 | PF07677 | |
| Domain | A2M_comp | 1.22e-03 | 10 | 99 | 2 | PF07678 | |
| Domain | A2M_N | 1.22e-03 | 10 | 99 | 2 | PF01835 | |
| Domain | A2M_N | 1.22e-03 | 10 | 99 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 1.22e-03 | 10 | 99 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 1.22e-03 | 10 | 99 | 2 | PS00477 | |
| Domain | A2M_N_2 | 1.22e-03 | 10 | 99 | 2 | PF07703 | |
| Domain | Macroglobln_a2 | 1.22e-03 | 10 | 99 | 2 | IPR001599 | |
| Domain | Ig-like_dom | 1.41e-03 | 503 | 99 | 9 | IPR007110 | |
| Domain | - | 1.48e-03 | 11 | 99 | 2 | 4.10.110.10 | |
| Domain | PKD | 1.48e-03 | 11 | 99 | 2 | PS50093 | |
| Domain | PKD_dom | 1.48e-03 | 11 | 99 | 2 | IPR000601 | |
| Domain | - | 1.48e-03 | 11 | 99 | 2 | 2.60.40.670 | |
| Domain | Neurotransmitter_ion_chnl_CS | 1.74e-03 | 45 | 99 | 3 | IPR018000 | |
| Domain | P_trefoil_dom | 1.77e-03 | 12 | 99 | 2 | IPR000519 | |
| Domain | C8 | 1.77e-03 | 12 | 99 | 2 | PF08742 | |
| Domain | TIL | 1.77e-03 | 12 | 99 | 2 | PF01826 | |
| Domain | - | 1.77e-03 | 12 | 99 | 2 | 1.50.10.20 | |
| Domain | Neur_chan_memb | 1.86e-03 | 46 | 99 | 3 | PF02932 | |
| Domain | Neurotrans-gated_channel_TM | 1.98e-03 | 47 | 99 | 3 | IPR006029 | |
| Domain | - | 1.98e-03 | 47 | 99 | 3 | 2.70.170.10 | |
| Domain | Neur_chan_LBD | 1.98e-03 | 47 | 99 | 3 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 1.98e-03 | 47 | 99 | 3 | PS00236 | |
| Domain | Neur_channel | 1.98e-03 | 47 | 99 | 3 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 1.98e-03 | 47 | 99 | 3 | IPR006202 | |
| Domain | Unchr_dom_Cys-rich | 2.09e-03 | 13 | 99 | 2 | IPR014853 | |
| Domain | C8 | 2.09e-03 | 13 | 99 | 2 | SM00832 | |
| Domain | TIL_dom | 2.43e-03 | 14 | 99 | 2 | IPR002919 | |
| Domain | SEA | 2.43e-03 | 14 | 99 | 2 | SM00200 | |
| Domain | ADH_SHORT | 2.79e-03 | 53 | 99 | 3 | PS00061 | |
| Domain | adh_short | 3.10e-03 | 55 | 99 | 3 | PF00106 | |
| Domain | ARM-like | 3.15e-03 | 270 | 99 | 6 | IPR011989 | |
| Domain | VWF_type-D | 3.18e-03 | 16 | 99 | 2 | IPR001846 | |
| Domain | VWFD | 3.18e-03 | 16 | 99 | 2 | PS51233 | |
| Domain | VWD | 3.18e-03 | 16 | 99 | 2 | SM00216 | |
| Domain | VWD | 3.18e-03 | 16 | 99 | 2 | PF00094 | |
| Domain | SDR_fam | 3.27e-03 | 56 | 99 | 3 | IPR002347 | |
| Domain | Gal_mutarotase_SF_dom | 3.59e-03 | 17 | 99 | 2 | IPR011013 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 4.03e-03 | 18 | 99 | 2 | PS00754 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 4.03e-03 | 18 | 99 | 2 | IPR008930 | |
| Domain | Ig-like_fold | 4.22e-03 | 706 | 99 | 10 | IPR013783 | |
| Domain | SNF | 4.48e-03 | 19 | 99 | 2 | PF00209 | |
| Domain | Na/ntran_symport | 4.48e-03 | 19 | 99 | 2 | IPR000175 | |
| Domain | VWC_out | 4.48e-03 | 19 | 99 | 2 | SM00215 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 4.48e-03 | 19 | 99 | 2 | PS00610 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 4.48e-03 | 19 | 99 | 2 | PS50267 | |
| Domain | IG_LIKE | 4.57e-03 | 491 | 99 | 8 | PS50835 | |
| Pathway | BIOCARTA_FLUMAZENIL_PATHWAY | 1.44e-05 | 9 | 80 | 3 | M22034 | |
| Pathway | WP_STEROID_BIOSYNTHESIS | 1.44e-05 | 9 | 80 | 3 | MM15903 | |
| Pathway | BIOCARTA_GABA_PATHWAY | 2.05e-05 | 10 | 80 | 3 | M477 | |
| Pathway | WP_STEROID_BIOSYNTHESIS | 2.05e-05 | 10 | 80 | 3 | M39538 | |
| Pathway | WP_GABA_RECEPTOR_SIGNALING | 2.69e-05 | 31 | 80 | 4 | M39369 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 9.34e-05 | 16 | 80 | 3 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 1.13e-04 | 17 | 80 | 3 | M27412 | |
| Pathway | REACTOME_FCGR_ACTIVATION | 1.55e-04 | 48 | 80 | 4 | MM17214 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 2.17e-04 | 21 | 80 | 3 | MM15706 | |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 2.45e-04 | 54 | 80 | 4 | MM14655 | |
| Pathway | REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS | 2.82e-04 | 56 | 80 | 4 | MM14815 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 2.87e-04 | 23 | 80 | 3 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 4.16e-04 | 26 | 80 | 3 | M27483 | |
| Pathway | REACTOME_MINERALOCORTICOID_BIOSYNTHESIS | 4.70e-04 | 6 | 80 | 2 | M27075 | |
| Pathway | WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE | 8.71e-04 | 8 | 80 | 2 | MM15965 | |
| Pathway | WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS | 1.12e-03 | 9 | 80 | 2 | M46465 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 1.25e-03 | 211 | 80 | 6 | MM14502 | |
| Pathway | WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION | 1.29e-03 | 38 | 80 | 3 | M39854 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 1.32e-03 | 84 | 80 | 4 | MM14653 | |
| Pathway | REACTOME_CLASSICAL_ANTIBODY_MEDIATED_COMPLEMENT_ACTIVATION | 1.39e-03 | 39 | 80 | 3 | MM17212 | |
| Pathway | BIOCARTA_GABA_PATHWAY | 1.39e-03 | 10 | 80 | 2 | MM1401 | |
| Pathway | REACTOME_GLUCOCORTICOID_BIOSYNTHESIS | 1.39e-03 | 10 | 80 | 2 | M27076 | |
| Pubmed | 1.09e-11 | 8 | 102 | 5 | 11901193 | ||
| Pubmed | Exon shuffling generates an immunoglobulin heavy chain gene. | 3.48e-10 | 5 | 102 | 4 | 6769120 | |
| Pubmed | Chromosomal location of the structural gene cluster encoding murine immunoglobulin heavy chains. | 3.48e-10 | 5 | 102 | 4 | 6770027 | |
| Pubmed | Channel catfish soluble FcmuR binds conserved linear epitopes present on Cmu3 and Cmu4. | 3.48e-10 | 5 | 102 | 4 | 20031218 | |
| Pubmed | 3.48e-10 | 5 | 102 | 4 | 3031474 | ||
| Pubmed | Organization, structure, and assembly of immunoglobulin heavy chain diversity DNA segments. | 3.48e-10 | 5 | 102 | 4 | 6798155 | |
| Pubmed | Repetitive sequences in class-switch recombination regions of immunoglobulin heavy chain genes. | 3.48e-10 | 5 | 102 | 4 | 6781756 | |
| Pubmed | 3.48e-10 | 5 | 102 | 4 | 9707605 | ||
| Pubmed | Dynamic regulation of B cell complement signaling is integral to germinal center responses. | 8.37e-10 | 16 | 102 | 5 | 34031614 | |
| Pubmed | 1.04e-09 | 6 | 102 | 4 | 29531165 | ||
| Pubmed | 1.04e-09 | 6 | 102 | 4 | 37033932 | ||
| Pubmed | Organization of the constant-region gene family of the mouse immunoglobulin heavy chain. | 1.04e-09 | 6 | 102 | 4 | 6804095 | |
| Pubmed | B cell-intrinsic CD84 and Ly108 maintain germinal center B cell tolerance. | 1.04e-09 | 6 | 102 | 4 | 25801429 | |
| Pubmed | 1.04e-09 | 6 | 102 | 4 | 25348086 | ||
| Pubmed | Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphoma. | 1.04e-09 | 6 | 102 | 4 | 34050029 | |
| Pubmed | 1.04e-09 | 6 | 102 | 4 | 34621263 | ||
| Pubmed | 2.42e-09 | 7 | 102 | 4 | 38458187 | ||
| Pubmed | 2.42e-09 | 7 | 102 | 4 | 33193409 | ||
| Pubmed | 2.42e-09 | 7 | 102 | 4 | 25505290 | ||
| Pubmed | Histone demethylase LSD1 is required for germinal center formation and BCL6-driven lymphomagenesis. | 2.42e-09 | 7 | 102 | 4 | 30538335 | |
| Pubmed | The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers. | 2.42e-09 | 7 | 102 | 4 | 23001146 | |
| Pubmed | 2.42e-09 | 7 | 102 | 4 | 25921526 | ||
| Pubmed | 2.42e-09 | 7 | 102 | 4 | 29996101 | ||
| Pubmed | 2.42e-09 | 7 | 102 | 4 | 30274972 | ||
| Pubmed | FcgammaRI-deficient mice show multiple alterations to inflammatory and immune responses. | 4.84e-09 | 8 | 102 | 4 | 11911823 | |
| Pubmed | 4.84e-09 | 8 | 102 | 4 | 33432228 | ||
| Pubmed | 4.84e-09 | 8 | 102 | 4 | 14988498 | ||
| Pubmed | 4.84e-09 | 8 | 102 | 4 | 6774258 | ||
| Pubmed | 4.84e-09 | 8 | 102 | 4 | 18542049 | ||
| Pubmed | 4.84e-09 | 8 | 102 | 4 | 21037092 | ||
| Pubmed | Functional interplay of Epstein-Barr virus oncoproteins in a mouse model of B cell lymphomagenesis. | 8.69e-09 | 9 | 102 | 4 | 32522871 | |
| Pubmed | FcγRIV deletion reveals its central role for IgG2a and IgG2b activity in vivo. | 8.69e-09 | 9 | 102 | 4 | 20974962 | |
| Pubmed | Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice. | 8.69e-09 | 9 | 102 | 4 | 8552190 | |
| Pubmed | Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis. | 8.69e-09 | 9 | 102 | 4 | 24200695 | |
| Pubmed | TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory Fate. | 8.69e-09 | 9 | 102 | 4 | 32619424 | |
| Pubmed | The absence of IgE antibody-mediated augmentation of immune responses in CD23-deficient mice. | 8.69e-09 | 9 | 102 | 4 | 8041705 | |
| Pubmed | Cyclin D3 Governs Clonal Expansion of Dark Zone Germinal Center B Cells. | 1.44e-08 | 10 | 102 | 4 | 33207194 | |
| Pubmed | 1.44e-08 | 10 | 102 | 4 | 17675251 | ||
| Pubmed | Development of Th1-type immune responses requires the type I cytokine receptor TCCR. | 2.26e-08 | 11 | 102 | 4 | 11057672 | |
| Pubmed | Differential requirements of CD45 for lymphocyte development and function. | 2.26e-08 | 11 | 102 | 4 | 8566034 | |
| Pubmed | 2.26e-08 | 11 | 102 | 4 | 11911824 | ||
| Pubmed | 2.26e-08 | 11 | 102 | 4 | 27566940 | ||
| Pubmed | Direct regulation of Gata3 expression determines the T helper differentiation potential of Notch. | 2.26e-08 | 11 | 102 | 4 | 17658279 | |
| Pubmed | Cbl Ubiquitin Ligases Control B Cell Exit from the Germinal-Center Reaction. | 2.26e-08 | 11 | 102 | 4 | 29562201 | |
| Pubmed | IgH isotype-specific B cell receptor expression influences B cell fate. | 3.39e-08 | 12 | 102 | 4 | 28923960 | |
| Pubmed | 9.28e-08 | 15 | 102 | 4 | 20176268 | ||
| Pubmed | Nucleotide sequences of gene segments encoding membrane domains of immunoglobulin gamma chains. | 9.78e-08 | 4 | 102 | 3 | 6283537 | |
| Pubmed | Somatic mutation in genes for the variable portion of the immunoglobulin heavy chain. | 9.78e-08 | 4 | 102 | 3 | 6801765 | |
| Pubmed | Sequence analysis of cloned cDNA encoding part of an immunoglobulin heavy chain. | 9.78e-08 | 4 | 102 | 3 | 113776 | |
| Pubmed | Highly specific anti-estradiol antibodies: structural characterisation and binding diversity. | 9.78e-08 | 4 | 102 | 3 | 11812141 | |
| Pubmed | 9.78e-08 | 4 | 102 | 3 | 6794027 | ||
| Pubmed | 9.78e-08 | 4 | 102 | 3 | 6306571 | ||
| Pubmed | Further evidence that BALB/c and C57BL/6 gamma 2a genes originate from two distinct isotypes. | 9.78e-08 | 4 | 102 | 3 | 2510996 | |
| Pubmed | Spontaneous deletions in Ig heavy chain genes: flanking sequences influence splice site selection. | 9.78e-08 | 4 | 102 | 3 | 1754385 | |
| Pubmed | Sialic acid residues are essential for the anaphylactic activity of murine IgG1 antibodies. | 9.78e-08 | 4 | 102 | 3 | 19050247 | |
| Pubmed | 9.78e-08 | 4 | 102 | 3 | 1672339 | ||
| Pubmed | An autoimmune disease variant of IgG1 modulates B cell activation and differentiation. | 9.78e-08 | 4 | 102 | 3 | 30287618 | |
| Pubmed | 9.78e-08 | 4 | 102 | 3 | 7892607 | ||
| Pubmed | 9.78e-08 | 4 | 102 | 3 | 4565406 | ||
| Pubmed | Recognition of a cell-surface oligosaccharide of pathogenic Salmonella by an antibody Fab fragment. | 9.78e-08 | 4 | 102 | 3 | 1713710 | |
| Pubmed | 9.78e-08 | 4 | 102 | 3 | 6777755 | ||
| Pubmed | The roles of gamma 1 heavy chain membrane expression and cytoplasmic tail in IgG1 responses. | 9.78e-08 | 4 | 102 | 3 | 9103199 | |
| Pubmed | 9.78e-08 | 4 | 102 | 3 | 6297797 | ||
| Pubmed | Evolution of immunoglobulin subclasses. Primary structure of a murine myeloma gamma1 chain. | 9.78e-08 | 4 | 102 | 3 | 98524 | |
| Pubmed | IgG1 protects against renal disease in a mouse model of cryoglobulinaemia. | 9.78e-08 | 4 | 102 | 3 | 25363774 | |
| Pubmed | 9.78e-08 | 4 | 102 | 3 | 20621099 | ||
| Pubmed | 9.78e-08 | 4 | 102 | 3 | 38268239 | ||
| Pubmed | Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98). | 9.78e-08 | 4 | 102 | 3 | 12414967 | |
| Pubmed | Gene segments encoding transmembrane carboxyl termini of immunoglobulin gamma chains. | 9.78e-08 | 4 | 102 | 3 | 6799207 | |
| Pubmed | 9.78e-08 | 4 | 102 | 3 | 6787604 | ||
| Pubmed | Shutdown of class switch recombination by deletion of a switch region control element. | 9.78e-08 | 4 | 102 | 3 | 8438159 | |
| Pubmed | 9.78e-08 | 4 | 102 | 3 | 4098598 | ||
| Pubmed | 9.78e-08 | 4 | 102 | 3 | 6253932 | ||
| Pubmed | Immunoglobulin gamma 1 heavy chain gene: structural gene sequences cloned in a bacterial plasmid. | 9.78e-08 | 4 | 102 | 3 | 6769752 | |
| Pubmed | Mouse immunoglobulin allotypes: post-duplication divergence of gamma 2a and gamma 2b chain genes. | 9.78e-08 | 4 | 102 | 3 | 6803173 | |
| Pubmed | 9.78e-08 | 4 | 102 | 3 | 6170065 | ||
| Pubmed | 9.78e-08 | 4 | 102 | 3 | 6264445 | ||
| Pubmed | Distinction of the memory B cell response to cognate antigen versus bystander inflammatory signals. | 9.78e-08 | 4 | 102 | 3 | 19703988 | |
| Pubmed | 9.78e-08 | 4 | 102 | 3 | 2878362 | ||
| Pubmed | IgG1 deficiency exacerbates experimental autoimmune myasthenia gravis in BALB/c mice. | 9.78e-08 | 4 | 102 | 3 | 25867470 | |
| Pubmed | 9.78e-08 | 4 | 102 | 3 | 1542303 | ||
| Pubmed | 9.78e-08 | 4 | 102 | 3 | 9725203 | ||
| Pubmed | Nucleotide sequences of all the gamma gene loci of murine immunoglobulin heavy chains. | 9.78e-08 | 4 | 102 | 3 | 9126488 | |
| Pubmed | Rearrangement of immunoglobulin gamma 1-chain gene and mechanism for heavy-chain class switch. | 9.78e-08 | 4 | 102 | 3 | 6767246 | |
| Pubmed | 9.78e-08 | 4 | 102 | 3 | 12051834 | ||
| Pubmed | 9.78e-08 | 4 | 102 | 3 | 8683112 | ||
| Pubmed | 9.78e-08 | 4 | 102 | 3 | 8452816 | ||
| Pubmed | Genes for immunoglobulin heavy chain and serum prealbumin protein are linked in mouse. | 9.78e-08 | 4 | 102 | 3 | 807855 | |
| Pubmed | 9.78e-08 | 4 | 102 | 3 | 4166666 | ||
| Pubmed | 9.78e-08 | 4 | 102 | 3 | 26201558 | ||
| Pubmed | 9.78e-08 | 4 | 102 | 3 | 6249338 | ||
| Pubmed | 9.78e-08 | 4 | 102 | 3 | 6804950 | ||
| Pubmed | Integrin-dependent organization and bidirectional vesicular traffic at cytotoxic immune synapses. | 9.78e-08 | 4 | 102 | 3 | 19592272 | |
| Pubmed | 9.78e-08 | 4 | 102 | 3 | 10720538 | ||
| Pubmed | 9.78e-08 | 4 | 102 | 3 | 4831970 | ||
| Pubmed | 9.78e-08 | 4 | 102 | 3 | 7439686 | ||
| Pubmed | 9.78e-08 | 4 | 102 | 3 | 24752300 | ||
| Pubmed | 9.78e-08 | 4 | 102 | 3 | 15699144 | ||
| Pubmed | 9.78e-08 | 4 | 102 | 3 | 6278424 | ||
| Pubmed | 9.78e-08 | 4 | 102 | 3 | 35133976 | ||
| Interaction | P2RX6 interactions | 4.40e-07 | 59 | 99 | 6 | int:P2RX6 | |
| Interaction | CERS3 interactions | 5.38e-07 | 61 | 99 | 6 | int:CERS3 | |
| GeneFamily | CD molecules|Mucins | 1.63e-06 | 21 | 76 | 4 | 648 | |
| GeneFamily | Short chain dehydrogenase/reductase superfamily | 1.68e-05 | 76 | 76 | 5 | 743 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 6.59e-05 | 19 | 76 | 3 | 563 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 6.16e-04 | 9 | 76 | 2 | 1234 | |
| GeneFamily | Endogenous ligands|C1q and TNF related | 2.55e-03 | 18 | 76 | 2 | 1372 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 3.48e-03 | 21 | 76 | 2 | 813 | |
| Coexpression | NABA_ECM_AFFILIATED | 4.40e-06 | 170 | 101 | 7 | M5880 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP | 4.97e-06 | 245 | 101 | 8 | M18095 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP | 9.31e-06 | 267 | 101 | 8 | MM984 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | 1.16e-05 | 363 | 101 | 9 | M41103 | |
| Coexpression | FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_UP | PODXL ADGRG4 RYK CLCN5 TCERG1 IGHG1 IGHM KAT6B PCDH9 HSPA8 MUC20 | 1.67e-05 | 587 | 101 | 11 | M40869 |
| Coexpression | VANASSE_BCL2_TARGETS_UP | 2.28e-05 | 43 | 101 | 4 | MM799 | |
| Coexpression | DESCARTES_FETAL_STOMACH_MUC13_DMBT1_POSITIVE_CELLS | 3.74e-05 | 97 | 101 | 5 | M40301 | |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_12H_DN | 3.97e-05 | 162 | 101 | 6 | M7002 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_POSITIVE | 3.97e-05 | 162 | 101 | 6 | M41204 | |
| Coexpression | LEIN_CHOROID_PLEXUS_MARKERS | 5.47e-05 | 105 | 101 | 5 | M1719 | |
| Coexpression | LEIN_CHOROID_PLEXUS_MARKERS | 6.54e-05 | 109 | 101 | 5 | MM1214 | |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_PLASMA_CELLS | 7.02e-05 | 21 | 101 | 3 | M39281 | |
| Coexpression | DESCARTES_FETAL_HEART_EPICARDIAL_FAT_CELLS | 7.13e-05 | 111 | 101 | 5 | M40192 | |
| Coexpression | YOSHIMURA_MAPK8_TARGETS_UP | ATP7B NRCAM SI ADH1C SLC6A11 IGHG1 IGHM PTPRQ HSD3B1 HSD17B4 ADGRL2 PCCB KCNT1 GABRA3 GABRA6 | 1.14e-04 | 1281 | 101 | 15 | M1884 |
| Coexpression | ZHENG_FOXP3_TARGETS_IN_THYMUS_UP | 1.24e-04 | 199 | 101 | 6 | M1746 | |
| Coexpression | GSE7548_DAY7_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_DN | 1.24e-04 | 199 | 101 | 6 | M6843 | |
| Coexpression | GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_UP | 1.27e-04 | 200 | 101 | 6 | M9317 | |
| Coexpression | GSE17721_PAM3CSK4_VS_CPG_8H_BMDC_UP | 1.27e-04 | 200 | 101 | 6 | M3865 | |
| Coexpression | ZHENG_FOXP3_TARGETS_IN_THYMUS_UP | 1.27e-04 | 200 | 101 | 6 | MM1033 | |
| Coexpression | RASHI_RESPONSE_TO_IONIZING_RADIATION_6 | 1.61e-04 | 132 | 101 | 5 | MM996 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | ZBTB38 RAPGEF6 COPB1 SUSD6 RBBP6 SYNE1 FRYL WNK1 AP3M1 CD84 CD3E ATXN7 KAT6B SPEN HSPA8 HCLS1 | 1.82e-04 | 1492 | 101 | 16 | M40023 |
| Coexpression | VALK_AML_CLUSTER_1 | 1.89e-04 | 29 | 101 | 3 | M19844 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | 2.08e-04 | 219 | 101 | 6 | M41199 | |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_500_k-means-cluster#4 | 4.40e-06 | 24 | 99 | 4 | Arv_SC-H9hpx_500_K4 | |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500_k-means-cluster#3 | 1.64e-05 | 33 | 99 | 4 | Arv_SC-hpx_blastocyst_500_K3 | |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000_k-means-cluster#5 | 6.06e-05 | 89 | 99 | 5 | Arv_SC-hpx_blastocyst_1000_K5 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200 | 6.56e-05 | 147 | 99 | 6 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_200 | |
| ToppCell | COVID-19_Severe-multiplets|COVID-19_Severe / disease group, cell group and cell class | 6.17e-08 | 152 | 102 | 7 | 451745151322c2fcea22dbb3dba681e12634a510 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.19e-07 | 183 | 102 | 7 | 01664fce6b70a02c9d39d747b6a6aabc86d57bc2 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.27e-07 | 184 | 102 | 7 | ed7a8e79e5723a5f5a03f542203d9e50bdef5f50 | |
| ToppCell | 3'-Pediatric_IBD|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.36e-07 | 195 | 102 | 7 | 728776511e1f40f127f80ef1eecda6d6ad082392 | |
| ToppCell | metastatic_Brain-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 3.48e-07 | 196 | 102 | 7 | c17e105e47446a48aa06e1a3810828e20aa56ea9 | |
| ToppCell | AT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 3.60e-07 | 197 | 102 | 7 | 5e0d222872a25bb9e9069d3dffda2844bb69874a | |
| ToppCell | Transverse-B_cell-B_cell_IgG_Plasma|B_cell / Region, Cell class and subclass | 3.60e-07 | 197 | 102 | 7 | a0a096e8e80763a92d5d7396eb678a4587771a3a | |
| ToppCell | COVID_vent-Lymphocytic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.73e-07 | 198 | 102 | 7 | ee80f647317377081b4bd194ee2801f556b3a53b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.86e-07 | 199 | 102 | 7 | 928a3dbef54a2c292a71edb398d64dd54c259164 | |
| ToppCell | tumor_Lung-Fibroblasts-COL14A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 3.86e-07 | 199 | 102 | 7 | 0d1f2b0d10c1f8ee10c448659b2a22ea0a6a6f0d | |
| ToppCell | PBMC-Severe|PBMC / Compartment, Disease Groups and Clusters | 3.86e-07 | 199 | 102 | 7 | b428d95d3c90b28f658f652a768588a8ced4abd9 | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 3.86e-07 | 199 | 102 | 7 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | Mild-Lymphoid-Plasma|Mild / Condition, Lineage, Cell class and cell subclass | 1.87e-06 | 160 | 102 | 6 | 7fdb849f5caf5a127a2582326215e11f8eb4fa0e | |
| ToppCell | Mild-Lymphoid-Plasma-|Mild / Condition, Lineage, Cell class and cell subclass | 1.87e-06 | 160 | 102 | 6 | aa79848913910c01249d6cacf4ed53ec0e4f5c3d | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.40e-06 | 167 | 102 | 6 | ded4d6cccd3660662f12cf5a512de31d26325f1b | |
| ToppCell | Int-URO-Lymphocyte-B-B_intermediate|Int-URO / Disease, Lineage and Cell Type | 2.48e-06 | 168 | 102 | 6 | 5b3fb1fc8fea810c6d4e6feb42c24fb57e8066de | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.75e-06 | 171 | 102 | 6 | a2938e56cb5749004317798dc7ac0f0c2d4d8ae0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.84e-06 | 172 | 102 | 6 | 1565f38266891c3acf49778838de134c5dee5460 | |
| ToppCell | ASK428-Immune-B_cell|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.04e-06 | 174 | 102 | 6 | b5a7a612a515736cf3489afd0f6ad2054d54526f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.35e-06 | 177 | 102 | 6 | 64b8f665fdaf975558af2ad7d9b54d206de8350c | |
| ToppCell | 3'_v3-lymph-node_spleen-Mast-Mast_cell_lympho|lymph-node_spleen / Manually curated celltypes from each tissue | 3.35e-06 | 177 | 102 | 6 | 53040dbeb18574a48e352e4bce252c7c3018762c | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.81e-06 | 181 | 102 | 6 | 3dcb74b28f93be35ddf4de1937f7e30b25e11927 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.81e-06 | 181 | 102 | 6 | 7679a5980011d6dfb1aaca7abf678c29b6f819bb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.94e-06 | 182 | 102 | 6 | 9c120ddd109103ef6fac9c32b84d16a7624d0580 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.94e-06 | 182 | 102 | 6 | 041bc819e6cf2618bf86bce8dfe2df673f392ba3 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 4.33e-06 | 185 | 102 | 6 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.46e-06 | 186 | 102 | 6 | bdd9d3a432aab46e733469b362f0064d35c1ac49 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 4.46e-06 | 186 | 102 | 6 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.60e-06 | 187 | 102 | 6 | 9042bd0f57213a51503d9df2e4dce3209b7772d3 | |
| ToppCell | severe_influenza-B_intermediate|severe_influenza / disease group, cell group and cell class (v2) | 4.60e-06 | 187 | 102 | 6 | d6db8595aa72fdabc4a056ba6ce09876868a66d5 | |
| ToppCell | COPD|World / Disease state, Lineage and Cell class | 4.89e-06 | 189 | 102 | 6 | 53577632683686dc493a5a3fdc01887ec5c320f2 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.04e-06 | 190 | 102 | 6 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.19e-06 | 191 | 102 | 6 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | Enterocyte_Progenitors-C_06|Enterocyte_Progenitors / shred on cell type and cluster | 5.35e-06 | 192 | 102 | 6 | b9938e1a929c00628cc6ebfdf10cf285167f445c | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Paneth|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.68e-06 | 194 | 102 | 6 | 2f6e62a4ec8707bd5a16c0734c5131af55207ea2 | |
| ToppCell | C_06|World / shred on cell type and cluster | 5.68e-06 | 194 | 102 | 6 | 5cb42e09f380c4468cdc603ec0c3de35eadd3213 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.85e-06 | 195 | 102 | 6 | 23ab7e2a419377c05bab0e92a2457afbcd3d9e07 | |
| ToppCell | COVID-19_Severe|World / Disease condition and Cell class | 5.85e-06 | 195 | 102 | 6 | 22f56ccb81967bff54a1f90e949a8dfc2ce0e4ab | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.85e-06 | 195 | 102 | 6 | 1f07502597e9476345b07f9f25aeeb6c1de13013 | |
| ToppCell | ILEUM-inflamed|ILEUM / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.85e-06 | 195 | 102 | 6 | 661962a8bcd2b69894e889cb0681a5b0cdb8e819 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.85e-06 | 195 | 102 | 6 | 8a9d05f7a5397836b7dfb8ae4f7c4896042ac0fe | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.02e-06 | 196 | 102 | 6 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.02e-06 | 196 | 102 | 6 | 147dc1ca5942df48a083cce39a9a7541430f8365 | |
| ToppCell | severe-CD8+_Tem|World / disease stage, cell group and cell class | 6.02e-06 | 196 | 102 | 6 | b8156d31312660fe9c071cb10d7ef22af672c6c8 | |
| ToppCell | Caecum-B_cell-B_cell_IgG_Plasma|B_cell / Region, Cell class and subclass | 6.20e-06 | 197 | 102 | 6 | 40c8ff067e8242e2ca083ea04cd6026168191a97 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.20e-06 | 197 | 102 | 6 | bf10727fbe90b71d2ac60a11711e5f0701b3799d | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.38e-06 | 198 | 102 | 6 | 8d629492d2199de8e036c19e9dacceb9c9e721a0 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.38e-06 | 198 | 102 | 6 | 6e6af8fad09f8e48b3f2ce463d5773b6a69864d1 | |
| ToppCell | 5'-Adult-SmallIntestine|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.57e-06 | 199 | 102 | 6 | a5fffe381be1ba7d192b68d1d3937ce47663658e | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.57e-06 | 199 | 102 | 6 | 01c2721bc82cd672e9477029b4a7ecc77e2f1b00 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.57e-06 | 199 | 102 | 6 | 639539d27e8ea1cc47630a69668e6cba02f8c9ca | |
| ToppCell | Lung_Parenchyma-Severe|Lung_Parenchyma / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.76e-06 | 200 | 102 | 6 | 62502bb23ca732daed32c838ce9719093f3aaeb0 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.76e-06 | 200 | 102 | 6 | 27507c4b41d45c7cc50e4993169c0302be22ee34 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Endothelial-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 6.76e-06 | 200 | 102 | 6 | b65fb8d378abd91cdabf5faac5f4b90d527f8c44 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.76e-06 | 200 | 102 | 6 | 2cb6e35add34b9dc564ebcf5d3cbc761325ca9f4 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-B-B_intermediate|Int-URO / Disease, condition lineage and cell class | 6.76e-06 | 200 | 102 | 6 | 221dd8d8851c47f2202ba848de3a041b17b1db3f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.48e-06 | 123 | 102 | 5 | 511b7c20a4a85e49980936d52af7dbca19bb848e | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Syt6-Excitatory_NeuronSlc17a7-Slc17a6.Syt6-Nnat_(Deep_layer_pyramidal_cells--medial_cortex)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.92e-05 | 69 | 102 | 4 | de297aa59c70f15c55cb9570439dc6d3fd6c182b | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Syt6|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.92e-05 | 69 | 102 | 4 | 31f4fb56dfa5e3ad7c83e0770960c3617e4f66a7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.03e-05 | 144 | 102 | 5 | fca32b38d23fa4d213e553b929604a2796e9a929 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.98e-05 | 156 | 102 | 5 | d81e78bec5c8a3f3ec9e1447ebab2c5805b815eb | |
| ToppCell | COVID-19_Moderate-multiplets|World / disease group, cell group and cell class | 2.98e-05 | 156 | 102 | 5 | afdc025fa75e7926b1cc182c4a33654a2186abb1 | |
| ToppCell | COVID-naiveBc-|COVID / Condition, Cell_class and T cell subcluster | 3.27e-05 | 159 | 102 | 5 | 4e6783b0f69c0c70150f9f3594881dc1bac7038a | |
| ToppCell | COVID-naiveBc|COVID / Condition, Cell_class and T cell subcluster | 3.27e-05 | 159 | 102 | 5 | 52cd36b4412f69a935b3f76da96c166a9481eb0c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.27e-05 | 159 | 102 | 5 | d3f81ba22160568ccaa6d2b04ebfd30630f9a6db | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.58e-05 | 162 | 102 | 5 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| ToppCell | COVID-19_Severe-multiplets|World / disease group, cell group and cell class | 3.68e-05 | 163 | 102 | 5 | 6db4271c2d47a9c333964f36d2c32207115e52cd | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-ABC_aged-B_memory|bone_marrow / Manually curated celltypes from each tissue | 3.68e-05 | 163 | 102 | 5 | 30f5c93c4e170304d701b5231f0d545f404066f7 | |
| ToppCell | COVID-19-lung-Mesothelial|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.79e-05 | 164 | 102 | 5 | 83303e2ba52008391b8dc3fae8225ab5bcb20063 | |
| ToppCell | C_02|World / shred on cell type and cluster | 3.90e-05 | 165 | 102 | 5 | a456c2c9ffe8dc91e17cac84ba87b88e016f8e6d | |
| ToppCell | normal_Lymph_Node-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass | 4.02e-05 | 166 | 102 | 5 | d638d356592325cded4a6cb549041cf2f8d3e62c | |
| ToppCell | normal_Lung-T/NK_cells-CD8+/CD4+_Mixed_Th|normal_Lung / Location, Cell class and cell subclass | 4.02e-05 | 166 | 102 | 5 | ff32422390852546e0cb216192452e9c47bd9509 | |
| ToppCell | Club_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 4.13e-05 | 167 | 102 | 5 | dbdaaeb3bd9139cb008d9fe24ec031fc5628f136 | |
| ToppCell | ASK440-Immune-B_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.25e-05 | 168 | 102 | 5 | 127559d1a083c68cda9fce143afcc3eec168df17 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.25e-05 | 168 | 102 | 5 | e96859dbf51cf8c4def8ee8db132f4d874fb4381 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B_plasma|Lung / Manually curated celltypes from each tissue | 4.37e-05 | 169 | 102 | 5 | a65853ff9f6489cc1617cbba0d03b392d23c1528 | |
| ToppCell | tumor_Lymph_Node_/_Brain-B_lymphocytes-Plasma_cells|B_lymphocytes / Location, Cell class and cell subclass | 4.37e-05 | 169 | 102 | 5 | 150c08c7b1dc0f46173a7b8f6a3fc70d82906c0d | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.63e-05 | 171 | 102 | 5 | 5e93c76ee60f9d0590ebb140812653a5e1369417 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.89e-05 | 173 | 102 | 5 | 7e6bfe85f60834f317941b70d6e0dc3bd527d293 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-B-CD5+_CCL22+_mature_B|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.16e-05 | 175 | 102 | 5 | fa53ea81ad943a2cd266114829135cbcbcf2f634 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.16e-05 | 175 | 102 | 5 | e5467dacf81f1f913b1719931cf1a7331434a7e7 | |
| ToppCell | COVID-19-kidney-Podocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.16e-05 | 175 | 102 | 5 | a73e3a65fd5c1e09cb0c2dae20c1a7bfcae49223 | |
| ToppCell | ASK428-Immune-B_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.16e-05 | 175 | 102 | 5 | e0979e5795a49b4e5c9b88e7fe6b7bda7a413a6c | |
| ToppCell | 10x5'-blood-Lymphocytic_B_plasma-Plasmablasts|blood / Manually curated celltypes from each tissue | 5.16e-05 | 175 | 102 | 5 | 2e048bf7961c3d86b6e12a1ebae3b3f2359af457 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.30e-05 | 176 | 102 | 5 | 8e7f38de8bf68077e2138f4d06c1f55b0fd096cc | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.30e-05 | 176 | 102 | 5 | ed575330a08a6748ea4b28433292c8cfd157d444 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.30e-05 | 176 | 102 | 5 | 64e426f5e84884ce2c29acf6f4b958962a63927f | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.45e-05 | 177 | 102 | 5 | 5ff8dcfb030312126695d53a026d2e104a401b83 | |
| ToppCell | COPD-Lymphoid-B_Plasma|COPD / Disease state, Lineage and Cell class | 5.45e-05 | 177 | 102 | 5 | 1b872d3b1e0fca138362098590a634d748dfca60 | |
| ToppCell | tumor_Lung-Endothelial_cells-EPCs|tumor_Lung / Location, Cell class and cell subclass | 5.45e-05 | 177 | 102 | 5 | f8b152c09d56a97e8c0482fb1a3964c05f9dc8c5 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.60e-05 | 178 | 102 | 5 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.60e-05 | 178 | 102 | 5 | dfed0fbf7a73b8a9e00178ec58dc4592b271c344 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.75e-05 | 179 | 102 | 5 | 056df2aaff750e0e283e7da78fcc3c90c366aac0 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.75e-05 | 179 | 102 | 5 | f5f3945ef3b9efc5921a71fd51deeb2c80f0ce11 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.75e-05 | 179 | 102 | 5 | d0fa700648db8ce76a8aa689879a25048299fa40 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.75e-05 | 179 | 102 | 5 | 2e49b215b71438400aebb483f2c2c08d5e956961 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-Tuft-related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.06e-05 | 181 | 102 | 5 | 1d3d1b5a6efe9cedd03b7e0b5684df97f0246729 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.06e-05 | 181 | 102 | 5 | e47664a264a2c37390d1668ce04eef2e0172f4cb | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-B_cells-CLP|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.06e-05 | 181 | 102 | 5 | 1110a0375189c034e6b02e6ebceb7084e4590114 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.06e-05 | 181 | 102 | 5 | 5bf7aa43f6e6ecce15c95928b91195544d6928c4 | |
| Drug | Meprobamate | 1.68e-06 | 6 | 101 | 3 | DB00371 | |
| Drug | Flunitrazepam | 1.68e-06 | 6 | 101 | 3 | DB01544 | |
| Drug | phenobarbital quinidine | 2.51e-06 | 22 | 101 | 4 | ctd:C033457 | |
| Drug | vigabatrin | 2.54e-06 | 49 | 101 | 5 | CID000005665 | |
| Drug | Ethchlorvynol | 6.98e-06 | 9 | 101 | 3 | DB00189 | |
| Drug | Secobarbital | 9.94e-06 | 10 | 101 | 3 | DB00418 | |
| Drug | Chlordiazepoxide | 9.94e-06 | 10 | 101 | 3 | DB00475 | |
| Drug | Metharbital | 9.94e-06 | 10 | 101 | 3 | DB00463 | |
| Drug | Pentobarbital | 9.94e-06 | 10 | 101 | 3 | DB00312 | |
| Drug | Talbutal | 9.94e-06 | 10 | 101 | 3 | DB00306 | |
| Drug | Clobazam | 9.94e-06 | 10 | 101 | 3 | DB00349 | |
| Drug | Butalbital | 9.94e-06 | 10 | 101 | 3 | DB00241 | |
| Drug | Butabarbital | 9.94e-06 | 10 | 101 | 3 | DB00237 | |
| Drug | Bromazepam | 9.94e-06 | 10 | 101 | 3 | DB01558 | |
| Drug | Barbituric acid derivative | 9.94e-06 | 10 | 101 | 3 | DB01496 | |
| Drug | Barbital | 9.94e-06 | 10 | 101 | 3 | DB01483 | |
| Drug | Hexobarbital | 9.94e-06 | 10 | 101 | 3 | DB01355 | |
| Drug | Aprobarbital | 9.94e-06 | 10 | 101 | 3 | DB01352 | |
| Drug | Amobarbital | 9.94e-06 | 10 | 101 | 3 | DB01351 | |
| Drug | Heptabarbital | 9.94e-06 | 10 | 101 | 3 | DB01354 | |
| Drug | Butethal | 9.94e-06 | 10 | 101 | 3 | DB01353 | |
| Drug | Methylphenobarbital | 9.94e-06 | 10 | 101 | 3 | DB00849 | |
| Drug | Oxazepam | 9.94e-06 | 10 | 101 | 3 | DB00842 | |
| Drug | Primidone | 9.94e-06 | 10 | 101 | 3 | DB00794 | |
| Drug | Midazolam | 9.94e-06 | 10 | 101 | 3 | DB00683 | |
| Drug | Flurazepam | 9.94e-06 | 10 | 101 | 3 | DB00690 | |
| Drug | trans-4-aminocrotonic acid | 1.21e-05 | 67 | 101 | 5 | CID000002766 | |
| Drug | Thiopental | 1.36e-05 | 11 | 101 | 3 | DB00599 | |
| Drug | Alprazolam | 1.36e-05 | 11 | 101 | 3 | DB00404 | |
| Drug | Temazepam | 1.36e-05 | 11 | 101 | 3 | DB00231 | |
| Drug | Nitrazepam | 1.36e-05 | 11 | 101 | 3 | DB01595 | |
| Drug | Lorazepam | 1.36e-05 | 11 | 101 | 3 | DB00186 | |
| Drug | Phenobarbital | 1.36e-05 | 11 | 101 | 3 | DB01174 | |
| Drug | Triazolam | 1.36e-05 | 11 | 101 | 3 | DB00897 | |
| Drug | Clorazepate | 1.36e-05 | 11 | 101 | 3 | DB00628 | |
| Drug | estazolam | 1.72e-05 | 35 | 101 | 4 | CID000003261 | |
| Drug | 3-oxo-delta 5-steroid | 1.95e-05 | 2 | 101 | 2 | CID000439372 | |
| Drug | DMCM | 2.40e-05 | 38 | 101 | 4 | CID000104999 | |
| Drug | clonazepam | 3.24e-05 | 82 | 101 | 5 | CID000002802 | |
| Drug | gaboxadol | 3.26e-05 | 41 | 101 | 4 | CID000003448 | |
| Drug | zolpidem | 3.94e-05 | 43 | 101 | 4 | CID000005732 | |
| Drug | thymol | 5.16e-05 | 46 | 101 | 4 | CID000006989 | |
| Drug | dihydroxyaflavinine | 5.51e-05 | 17 | 101 | 3 | CID000156857 | |
| Drug | 4-phenylthiosemicarbazide | 5.83e-05 | 3 | 101 | 2 | CID000730679 | |
| Drug | Ro 15-4513 | 9.14e-05 | 20 | 101 | 3 | CID000005081 | |
| Drug | delta-hexachlorocyclohexane | 9.14e-05 | 20 | 101 | 3 | ctd:C086916 | |
| Drug | chromomycin A3 | 9.65e-05 | 103 | 101 | 5 | CID000656673 | |
| Drug | turosteride | 1.16e-04 | 4 | 101 | 2 | CID000065986 | |
| Drug | Trilostane | 1.16e-04 | 4 | 101 | 2 | DB01108 | |
| Drug | D 256 | 1.16e-04 | 4 | 101 | 2 | CID003048134 | |
| Drug | C05489 | 1.16e-04 | 4 | 101 | 2 | CID000440708 | |
| Drug | flunitrazepam | 1.38e-04 | 59 | 101 | 4 | CID000003380 | |
| Drug | alpidem | 1.60e-04 | 24 | 101 | 3 | CID000054897 | |
| Drug | methohexital | 1.60e-04 | 24 | 101 | 3 | CID000009034 | |
| Drug | beta-CCM | 1.60e-04 | 24 | 101 | 3 | CID000107704 | |
| Drug | gamma-Aminobutyric Acid | 1.67e-04 | 62 | 101 | 4 | ctd:D005680 | |
| Drug | chloride | ATP7B WNK1 CBR1 ADH1C CD84 SLC6A11 CLC PTPRB CLCN5 SLC6A20 SLC26A11 GABRA3 GABRA4 GABRA6 | 1.78e-04 | 1029 | 101 | 14 | CID000000312 |
| Drug | isonipecotic acid | 1.82e-04 | 25 | 101 | 3 | CID000003773 | |
| Drug | beta-carboline | 1.89e-04 | 64 | 101 | 4 | CID000064961 | |
| Drug | 17alpha, 21-dihydroxypregnenolone | 1.93e-04 | 5 | 101 | 2 | CID000192735 | |
| Drug | 4-nitro-3-cresol | 1.93e-04 | 5 | 101 | 2 | ctd:C008636 | |
| Drug | Lorazepam | 1.93e-04 | 5 | 101 | 2 | ctd:D008140 | |
| Drug | picrotoxinine | 2.01e-04 | 65 | 101 | 4 | CID000004816 | |
| Drug | Ethoxyquin [91-53-2]; Down 200; 18.4uM; PC3; HT_HG-U133A | 2.23e-04 | 193 | 101 | 6 | 4321_DN | |
| Drug | Fusaric acid [536-69-6]; Down 200; 22.4uM; MCF7; HT_HG-U133A | 2.29e-04 | 194 | 101 | 6 | 4105_DN | |
| Drug | Spironolactone [52-01-7]; Up 200; 9.6uM; PC3; HT_HG-U133A | 2.36e-04 | 195 | 101 | 6 | 2064_UP | |
| Drug | enflurane | 2.39e-04 | 68 | 101 | 4 | CID000003226 | |
| Drug | Droperidol [548-73-2]; Down 200; 10.6uM; PC3; HT_HG-U133A | 2.42e-04 | 196 | 101 | 6 | 4629_DN | |
| Drug | Tomatidine [77-59-8]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 2.56e-04 | 198 | 101 | 6 | 7166_DN | |
| Drug | SB 203580; Down 200; 1uM; PC3; HT_HG-U133A | 2.56e-04 | 198 | 101 | 6 | 6894_DN | |
| Drug | Dipyrone [5907-38-0]; Down 200; 12uM; HL60; HT_HG-U133A | 2.70e-04 | 200 | 101 | 6 | 2175_DN | |
| Drug | H045 | 2.82e-04 | 71 | 101 | 4 | CID000003350 | |
| Drug | clobazam | 2.85e-04 | 29 | 101 | 3 | CID000002789 | |
| Drug | clotiazepam | 2.85e-04 | 29 | 101 | 3 | CID000002811 | |
| Drug | 21-hydroxypregnenolone | 2.89e-04 | 6 | 101 | 2 | CID000150891 | |
| Drug | Beta-D-Mannose | 2.89e-04 | 6 | 101 | 2 | DB02687 | |
| Drug | 16alpha-OHAD | 2.89e-04 | 6 | 101 | 2 | CID000160789 | |
| Drug | acetone hydrazone | 2.89e-04 | 6 | 101 | 2 | CID000078937 | |
| Drug | guvacine | 3.15e-04 | 30 | 101 | 3 | CID000003532 | |
| Drug | WIN 32729 | 3.15e-04 | 30 | 101 | 3 | CID000054579 | |
| Drug | 3-isothujone | 3.15e-04 | 30 | 101 | 3 | CID000011027 | |
| Disease | Malignant neoplasm of breast | ATP7B NRCAM ZSWIM5 SYNE1 BCORL1 CD109 WNK1 SLC2A2 EMSY SORCS1 SURF1 MROH7 KAT6B SPEN GABRA4 | 4.27e-06 | 1074 | 102 | 15 | C0006142 |
| Disease | neural cell adhesion molecule 1 measurement | 1.18e-05 | 2 | 102 | 2 | EFO_0801826 | |
| Disease | insulin growth factor-like family member 4 measurement | 1.18e-05 | 2 | 102 | 2 | EFO_0801701 | |
| Disease | ameloblastin measurement | 3.54e-05 | 3 | 102 | 2 | EFO_0801377 | |
| Disease | paired immunoglobulin-like type 2 receptor alpha measurement | 3.54e-05 | 3 | 102 | 2 | EFO_0801866 | |
| Disease | secretoglobin family 1C member 1 measurement | 3.54e-05 | 3 | 102 | 2 | EFO_0802041 | |
| Disease | di-N-acetylchitobiase measurement | 7.07e-05 | 4 | 102 | 2 | EFO_0801524 | |
| Disease | N,N-dimethylalanine measurement | 7.07e-05 | 4 | 102 | 2 | EFO_0800098 | |
| Disease | trem-like transcript 4 protein measurement | 7.07e-05 | 4 | 102 | 2 | EFO_0802160 | |
| Disease | sodium/potassium-transporting ATPase subunit alpha-1 measurement | 7.07e-05 | 4 | 102 | 2 | EFO_0802077 | |
| Disease | RING finger protein 165 measurement | 7.07e-05 | 4 | 102 | 2 | EFO_0802027 | |
| Disease | potassium voltage-gated channel subfamily E member 2 measurement | 1.18e-04 | 5 | 102 | 2 | EFO_0801901 | |
| Disease | protein shisa-3 homolog measurement | 1.18e-04 | 5 | 102 | 2 | EFO_0801964 | |
| Disease | Hypospadias | 1.18e-04 | 5 | 102 | 2 | C0848558 | |
| Disease | bipolar disorder (is_implicated_in) | 1.37e-04 | 29 | 102 | 3 | DOID:3312 (is_implicated_in) | |
| Disease | carcinoembryonic antigen-related cell adhesion molecule 1 measurement | 1.76e-04 | 6 | 102 | 2 | EFO_0801456 | |
| Disease | beta-sarcoglycan measurement | 1.76e-04 | 6 | 102 | 2 | EFO_0801422 | |
| Disease | multiple coagulation factor deficiency protein 2 measurement | 1.76e-04 | 6 | 102 | 2 | EFO_0801810 | |
| Disease | complement C1q subcomponent measurement | 1.76e-04 | 6 | 102 | 2 | EFO_0008089 | |
| Disease | SLAM family member 5 measurement | 2.46e-04 | 7 | 102 | 2 | EFO_0020741 | |
| Disease | inducible T-cell costimulator measurement | 2.46e-04 | 7 | 102 | 2 | EFO_0021967 | |
| Disease | Autistic Disorder | 3.00e-04 | 261 | 102 | 6 | C0004352 | |
| Disease | pulse pressure measurement | PODXL HEATR5A FRYL RYK ADH1C CD3E MTF1 ATXN7 LRP1 NADK C1QTNF7 MPPED2 NPAS2 GABRA6 | 3.10e-04 | 1392 | 102 | 14 | EFO_0005763 |
| Disease | hypospadias (is_implicated_in) | 3.27e-04 | 8 | 102 | 2 | DOID:10892 (is_implicated_in) | |
| Disease | sciatic neuropathy (biomarker_via_orthology) | 3.94e-04 | 99 | 102 | 4 | DOID:11446 (biomarker_via_orthology) | |
| Disease | hyperprolactinemia (biomarker_via_orthology) | 4.19e-04 | 9 | 102 | 2 | DOID:12700 (biomarker_via_orthology) | |
| Disease | axin-2 measurement | 5.23e-04 | 10 | 102 | 2 | EFO_0801400 | |
| Disease | Colorectal Carcinoma | 7.43e-04 | 702 | 102 | 9 | C0009402 | |
| Disease | Mouth Neoplasms | 8.75e-04 | 54 | 102 | 3 | C0026640 | |
| Disease | Malignant neoplasm of mouth | 8.75e-04 | 54 | 102 | 3 | C0153381 | |
| Disease | tumor necrosis factor ligand superfamily member 11 measurement | 9.00e-04 | 13 | 102 | 2 | EFO_0010617 | |
| Disease | asthma | 1.19e-03 | 751 | 102 | 9 | MONDO_0004979 | |
| Disease | Antibody Deficiency Syndrome | 1.56e-03 | 17 | 102 | 2 | C0003257 | |
| Disease | Familial Progressive Myoclonic Epilepsy | 1.56e-03 | 17 | 102 | 2 | C0751777 | |
| Disease | Atypical Inclusion-Body Disease | 1.56e-03 | 17 | 102 | 2 | C0751776 | |
| Disease | Myoclonic Epilepsies, Progressive | 1.56e-03 | 17 | 102 | 2 | C0751778 | |
| Disease | Biotin-Responsive Encephalopathy | 1.56e-03 | 17 | 102 | 2 | C0751780 | |
| Disease | May-White Syndrome | 1.56e-03 | 17 | 102 | 2 | C0751782 | |
| Disease | Dentatorubral-Pallidoluysian Atrophy | 1.56e-03 | 17 | 102 | 2 | C0751781 | |
| Disease | Sclerocystic Ovaries | 1.60e-03 | 144 | 102 | 4 | C1136382 | |
| Disease | Polycystic Ovary Syndrome | 1.60e-03 | 144 | 102 | 4 | C0032460 | |
| Disease | Action Myoclonus-Renal Failure Syndrome | 1.75e-03 | 18 | 102 | 2 | C0751779 | |
| Disease | COVID-19, osteoarthritis | 2.16e-03 | 20 | 102 | 2 | MONDO_0005178, MONDO_0100096 | |
| Disease | Mammary Carcinoma, Human | 2.34e-03 | 525 | 102 | 7 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 2.34e-03 | 525 | 102 | 7 | C1257931 | |
| Disease | Mammary Neoplasms | 2.39e-03 | 527 | 102 | 7 | C1458155 | |
| Disease | epilepsy (implicated_via_orthology) | 2.51e-03 | 163 | 102 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | Breast Carcinoma | 2.68e-03 | 538 | 102 | 7 | C0678222 | |
| Disease | Immunologic Deficiency Syndromes | 2.86e-03 | 23 | 102 | 2 | C0021051 | |
| Disease | cleft lip | 3.11e-03 | 284 | 102 | 5 | EFO_0003959 | |
| Disease | Sjogren's syndrome (is_marker_for) | 3.11e-03 | 24 | 102 | 2 | DOID:12894 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LSSVGKFSTVNPVYV | 211 | P26439 | |
| ILSSVGKFSTVNPVY | 211 | P14060 | |
| STLDVTPVIYAGATS | 1606 | Q8IZF6 | |
| VSLEQGSATVKYVPS | 91 | P35670 | |
| YGSAVKVAKVTPGST | 181 | P00326 | |
| TVIATVASSPAGYKT | 616 | P54259 | |
| STALISTIPGTYVGV | 706 | Q5H9F3 | |
| SGAISTATYTTVPRV | 116 | O75973 | |
| FIQTDKTIYTPGSTV | 131 | P01024 | |
| PATVVGVSAAIDYKS | 961 | O95490 | |
| TQGSYTFDPVTKVLT | 326 | Q9Y2T2 | |
| IKYSVGSLSPVSASV | 351 | Q9UBU7 | |
| KSDGSSLSPVTAAVY | 346 | O60312 | |
| LSIPSKSTVGTQTDY | 181 | Q7Z4T9 | |
| TITQASYVTLIPGSS | 291 | Q68CQ1 | |
| RPGATTKITTTSTYI | 406 | Q8WYB5 | |
| TTDGSIIYVSDSITP | 101 | Q99743 | |
| PSQGKVTITVDEYSS | 6 | Q15777 | |
| ETSTVPYKELTGATT | 4911 | Q8WXI7 | |
| YKATSAVVITSTSGD | 6326 | Q8WXI7 | |
| ITETSAVLYGVPTSA | 9891 | Q8WXI7 | |
| AVLYGVPTSATTEVS | 9896 | Q8WXI7 | |
| KISSSSSTVAIPGYT | 211 | O00592 | |
| VPGRLYSVTVTTKSG | 791 | P23467 | |
| ATSSPSVVYNASTKV | 871 | Q2M2H8 | |
| ANVSKYIVSGTPTFV | 801 | Q92823 | |
| LSVETPSYVKVSGAA | 536 | Q8N307 | |
| SSTYSLIPITVAEAG | 1371 | Q9BQS8 | |
| APSTSIYLEAKGTSV | 201 | Q96N19 | |
| SYASSAVTFPGIKLI | 186 | Q8N370 | |
| ATYLSGAQVSTITPT | 211 | Q07954 | |
| VTFSTVGYGDVTPKI | 291 | Q5JUK3 | |
| AVIVAPTSSGKTYAS | 781 | Q8IY21 | |
| AVIVAPTSSGKTYAS | 761 | Q5H9U9 | |
| VIVSTPTGSTAYAAA | 316 | O95544 | |
| YTISISSTAESGKKP | 331 | Q92824 | |
| TLKPGSYVSEATTAT | 6186 | Q7Z5P9 | |
| PKYSTVGVITVTDAD | 586 | Q9HC56 | |
| VAFTSSYTSTPVTQK | 151 | Q02505 | |
| SSPAVKYEAAGTLVT | 256 | P53618 | |
| RITSSYKIPSVTSGT | 1466 | O94915 | |
| STSIFQTAGISKPVY | 326 | P11168 | |
| VPYTEAASLSTGSTV | 6 | Q05315 | |
| TEVKTDIYVTSFGPV | 91 | P34903 | |
| KTSTTFNIVGTTYPI | 391 | P34903 | |
| VTEVKTDIYVTSFGP | 71 | P48169 | |
| TEVKTDIYVTSFGPV | 56 | Q16445 | |
| VSYLAAATVSTSPVL | 591 | O15265 | |
| PIGGVKSTSKTYVIS | 76 | Q7Z6E9 | |
| YSPLTTLKTVDSSGS | 261 | Q9NYR8 | |
| KITPSTEKGFSDTYT | 1166 | Q9UMZ3 | |
| SYLFITGPDVVKSVT | 221 | P05166 | |
| KKSVITYSPTTGTCQ | 26 | Q13352 | |
| TSGVSLEPVYSETFK | 991 | A4FU69 | |
| GNKSPVTLTAYIVTS | 1041 | Q6YHK3 | |
| SSSGATIKSPEDVYT | 1536 | Q86XA9 | |
| AEAKESGPTTYKVTS | 166 | P01871 | |
| AYVDLAPTSGTSAKT | 601 | P51659 | |
| LVYSAPTSAGKTLVA | 111 | O75417 | |
| IISETTYSGFPVVVS | 681 | P51795 | |
| ITQTPYKVSISGTTV | 31 | P07766 | |
| SSAYGVTKIGVTVLS | 191 | P16152 | |
| SSTGISYSIPSTSKQ | 256 | Q13495 | |
| KTSSYVGASIVTAVG | 31 | P57739 | |
| YTSAGISVTVKELFP | 176 | P12314 | |
| TAVFLATSGVPVYKV | 391 | Q8NCS7 | |
| VSAGTEKYILAPSSS | 311 | A6NC97 | |
| GLYSLSSVVTVPSSS | 61 | P01857 | |
| GLYSLSSVVTVPSSS | 61 | P01860 | |
| GLYSLSSVVTVPSSS | 61 | P01861 | |
| VPSSSLGTKTYTCNV | 71 | P01861 | |
| VTKSVKVFAEYPGSS | 196 | Q9H583 | |
| SNVVVLPSGSTVYVK | 176 | Q7Z589 | |
| LPSGSTVYVKSVSCS | 181 | Q7Z589 | |
| TTKLVTTPTGTQATY | 496 | Q7Z589 | |
| PGAATYVKTTSGSII | 526 | Q7Z589 | |
| VSPTGTAVSTLSYIS | 216 | Q8WYP5 | |
| PAAAFGTSVTSAKVA | 31 | Q86WA6 | |
| APTTSTRVFYISVGV | 221 | P34925 | |
| SSGITEQTVTIKPYS | 1146 | Q8TDX9 | |
| LKSAFSVGITTSYPE | 146 | Q9BXJ2 | |
| AASKTTYKTTGTPEE | 231 | Q3MIW9 | |
| PKTSSLIVTVASVFY | 266 | Q8NGL4 | |
| GKTVTNAVVTVPAYF | 136 | P11142 | |
| SSTEKGLIVYCVTSP | 1481 | Q8TEU7 | |
| TAAFPSSSGVIYTVA | 8021 | Q8NF91 | |
| PLVYATKFTVSVSGI | 136 | Q969N4 | |
| AYKKTTPIEAASSGT | 221 | P14317 | |
| VPSSSGTVYDRTTVL | 36 | Q14872 | |
| SKTSVAYVTPGDSET | 56 | Q9UIB8 | |
| LISSSTQSGAYVVTP | 151 | Q15526 | |
| TGPTVSDTLYDVKVA | 181 | P14410 | |
| IAPKSTSVFAVASVG | 6 | Q92537 | |
| SPYLSGVGVASVVVS | 81 | Q9NP91 | |
| TVTPDASVYSDIVGK | 66 | Q9ULP9 | |
| TASEPAVTYKVAISF | 211 | Q9P217 | |
| PKYVSATSVTSTSVT | 2541 | Q96T58 | |
| SPLSSAGVAYAIIST | 141 | Q96EK2 | |
| VGTGSASYSTIAPTV | 146 | Q6ZMD2 | |
| VSCPYVKTVATTKTG | 386 | O14776 | |
| YPVIKGFTSAAAVTI | 151 | Q86WA9 | |
| EAVVTSSYPVSVKQG | 6 | Q9P2H5 | |
| KTIFSTGTPVAAATV | 366 | Q9H0E3 | |
| GTKSTGKVVYVTATF | 246 | P48066 | |
| DKTGSSDPYVTVQVS | 616 | O14795 | |
| AVTVSSYAYTKVTGP | 1776 | O43151 | |
| VISYSGSAPSVIVHS | 706 | Q8NAP3 | |
| VVSSTALYPSVTVSA | 1441 | Q9H4A3 | |
| YTSGIIASKDTAPSI | 536 | Q8WY21 | |
| VSVLTYGAKSCPQTS | 316 | Q6X784 | |
| SQIPGVSVKSSSIYS | 2021 | Q9Y493 |